[P3] C | APVS2025

Session Details

Poster Session

[P3]C

Tue. Nov 11, 2025 4:40 PM - 5:10 PM JST
Tue. Nov 11, 2025 7:40 AM - 8:10 AM UTC

P3(4F)

[P3-003-C]Chicken Serum as An Effective Alternative to Horse Serum for Cultivation of Mycoplasma hyorhinis

*YI CHIA LI^1,2,3, Sin-Hang Ma², Wei-Hao Lin^1,2,3, Chao-Nan Lin^1,2,3, Ming-Tang Chiou^1,2,3 (1. Animal Disease Diagnostic Center, College of Veterinary Medicine, National Pingtung University of Science and Technology (Taiwan), 2. Department of Veterinary Medicine, College of Veterinary Medicine, National Pingtung University of Science and Technology (Taiwan), 3. Sustainable Swine Research Center, National Pingtung University of Science and Technology (Taiwan))

[P3-006-C]MYCOPLASMA HYOPNEUMONIE ELIMANATION ON A SOW FARM IN JAPAN

*Katsumasa KURE¹, Keiko TOYAMA¹ (1. Value Farm Consulting Co.,Ltd. (Japan))

[P3-009-C]Safety and efficacy of a novel porcine circovirus type 2 and Mycoplasma hyopneumoniae bivalent vaccine against Mycoplasma hyopneumoniae

*Wei-Ting Jiang^1,2,3, Chia-Hung Lin², Kun-Lin Kuo², Yu-Han Huang², Thuyen Quyen Ly², Yueh Peng Hung⁴, She-pin Hung⁴, Yen Yu Kuo⁴, Tzu Ting Peng⁴, Chao-Nan Lin^1,2,3, Ming-Tang Chiou^1,2,3, Wei-Hao Lin^1,2,3 (1. Animal Disease Diagnostic Center, College of Veterinary Medicine, National Pingtung University of Science and Technology (Taiwan), 2. Department of Veterinary Medicine, College of Veterinary Medicine, National Pingtung University of Science and Technology (Taiwan), 3. Sustainable Swine Research Center, National Pingtung University of Science and Technology (Taiwan), 4. Animmune Biotechnology Co., Ltd. (Taiwan))

[P3-012-C]A Case Study on Mycoplasma hyopneumoniae Surveillance in a Commercial Japanese Swine Farm.

*MITSUHARU OHKUBO¹, Hitoshi Yoshimura², Tadao Horii², Josuke Mago², Daisuke Tsukamoto³ (1. Hogvet Creation, Inc. (Japan), 2. Zoetis Japan Inc., Tokyo, Japan (Japan), 3. Japan Veterinary Medical Association, Tokyo, Japan (Japan))

[P3-015-C]PREVALENCE OF MYCOPLASMA SUIS IN TAIWAN BETWEEN 2023 AND 2025

Hung Chih Kuo¹, *Chu Yen Lin¹, Teng Yuan Lo¹, Ching Fen Wu¹ (1. Department of Veterinary Medicine, National Chiayi University (Taiwan))

[P3-018-C]A combined PCV2d and Mycoplasma hyopneumoniae vaccine efficiently prevents immune dysregulation caused by the respective pathogens

*István Kiss¹, Nimród Pálmai¹, Roman Krejci², Philippe Mazerolles², Ágnes Kemény³, Andrea Müllebner⁴, Catharina J. Duvigneau⁴, Krishna Latha⁵ (1. Scientific Support and Investigation Unit, Ceva-Phylaxia, Budapest (Hungary), 2. Ceva Santé Animale, Libourne (France), 3. Department of Physiology and Biochemistry, University of Veterinary Medicine, Budapest (Hungary), 4. Department for Biological Sciences and Pathobiology, University of Veterinary Medicine, Vienna (Austria), 5. Team PLOVER, Biogenovac, Ceva Santé Animale, Beaucouze (France))

[P3-021-C]Effects of Fisetin on Virulence of Actinobacillus Pleuropneumoniae

*qiyun He¹, Weicheng Bei¹ (1. Huazhong Agricultural University (China))

[P3-024-C]Immunogenicity and vaccine efficacy of Actinobacillus pleuropneumoniae-derived extracellular vesicles as a novel vaccine candidate

*Byoung Joo Seo¹, Su Hyun Park², Yun Hye Kim², Hyeon Jin Lee², Gyeong-Seo Park¹, Chonghan Kim¹, Young Bae Ryu², Woo Sik Kim² (1. Vaccine Lab, WOOGENE B&G CO., Ltd (Korea), 2. Functional Biomaterial Research Center, Korea Research Institute of Bioscience and Biotechnology (Korea))

[P3-027-C]ANTIMICROBIAL SUSCEPTIBILITY TESTING AND RESISTANCE GENE ANALYSIS OF ACTINOBACILLUS PLEUROPNEUMONIAE IN DISEASED PIGS IN TAIWAN

*Hung Chih Kuo¹, Tsu Chi Kung¹, Hsiu Ya Yang¹, Chao Min Wang¹, Szu Wei Huang¹ (1. Department of Veterinary Medicine, National Chiayi University (Taiwan))

[P3-030-C]Impact of App- and EP-like lung lesions on growth, carcass yield and economical return of finishing pigs

Steven Van Colen¹, Peggy De Backer¹, Gert-Jan de Reus², Olivier Ninet³, Higor Cotta³, *PREBEN MORTENSEN⁴ (1. Ceva Santé Animale, Belgium (Belgium), 2. Ceva Santé Animale, Netherlands (Netherlands), 3. Ceva Santé Animale, France (France), 4. Ceva Corporate Swine (France))

[P3-033-C]The situation of the porcine enzootic pneumonia and porcine pleuropneumonia assessment in Thailand by using lung lesion scoring at slaughterhouse

*Naritsara Boonraungrod¹, Thongchai Amonrattanaporn¹, Kanitta Jitpreuk¹, Noppon Jiranart¹, Phawinwit Lawananon¹, Kraiwat Chawong¹, Jutatip Somkham¹, Ariya Satirakieat¹, Sasithorn Numkanisorn¹, Worrapon Prucksayoungyuen¹, Nongnapas Ruangpet¹, Rangson Rojpradit¹, Nutcha Keratikul¹, Irawin Nimmansamai² (1. Ceva Animal Health (Thailand) Ltd. (Thailand), 2. Ceva Animal Health Asia Pacific (Thailand))

[P3-036-C]DETERMINING THE PREVALENCE OF PASTEURELLA MULTOCIDA IN SWINE IN VIETNAM

*Nguyet Anh Nguyen Chau¹, Huynh Pham Nguyen¹, Han Dang Thi Le ¹, Karl Alexander Fabros² (1. Elanco Vietnam (Viet Nam), 2. Elanco Malaysia (Malaysia))

[P3-039-C]Evaluating the Porcine Enzootic Pneumonia and Porcine Pleuropneumonia in Vietnam by using lung lesion scoring approach at slaughterhouses

Xuan Van Doan¹, *Tung Thanh Nguyen¹, Kien Van Dao¹, Hai Viet Le¹, Toan Ba Nguyen¹ (1. Ceva Vietnam (Viet Nam))

[P3-042-C]CONTROLLING GLAESSERELLA PARASUIS WITH A COMMERCIAL VACCINE IN AN INDUSTRIAL FARM IN CHINA

*wentao fei¹, Cong Li¹, Yuan Li¹, Yunliang Yao¹, Salvador Romero Aguilar² (1. HIPRA CHINA (China), 2. HIPRA HQ (Spain))

[P3-045-C]Annual surveillance of porcine enzootic pneumonia in Chinese slaughterhouse in 2024

Zeyang Zhang¹, *Jun Zhang^1,2, Nick Tang¹, Roman Krejci³, Philippe Mazerolles³ (1. Ceva Animal Health China (China), 2. College of Veterinary Medicine, Nanjing Agricultural University (China), 3. Ceva Animal Health France (France))

[P3-048-C]Efficacy of Tulathromycin Metaphylaxis Treatment in Reducing PRDC-Related Morbidity in PRRS-Unstable Nursery Pigs

*Panida Tippitak¹, Piyanut Boonmeepipit¹, Settasart Sonna¹, Eric Bousquet² (1. FA, Virbac (Thailand), 2. GMMD, Virbac (France))

[P3-051-C]Efficacy of an Inactivated Escherichia coli and Clostridium perfringens type C Vaccine in Controlling Neonatal Diarrhoea on a farm Co-infected with Rotavirus A

*Tianning Yang¹, Wentao Fei¹, Baohai Feng¹, Ming Hsun Wu², Joaquin Miguel Escuder² (1. HIPRA CHINA (China), 2. HIPRA (Spain))

[P3-054-C]Detection of Clostridium novyi Antibodies from Swine Sera in Taiwan

*Amos Liao¹, Chiafu Hsu¹, Joaquín Miguel², Chao-Nan Lin³, Ming-Tang Chiou³ (1. HIPRA Taiwan (Taiwan), 2. HIPRA Spain (Spain), 3. NPUST (Taiwan))

[P3-057-C]Efficacy of Apramycin, Doxycycline, Flavomycin, and Tylosin in Inhibiting Clostridium perfringens type A Isolated from Diarrheagenic Piglets

Natharin Ngamwongsatit^1,2, Boontarika Juntanupong¹, Suppanat Silathawornwong³, Kritiya Phitsanuwattana³, *Kampon Kaeoket¹ (1. Department of Clinical Sciences and Public Health, Faculty of Veterinary Science, Mahidol University, Nakhon Pathom, 73170 (Thailand), 2. Laboratory of Bacteria, Veterinary Diagnostic Center, Faculty of Veterinary Science, Mahidol University, Nakhon Pathom, 73170 (Thailand), 3. Huvepharma (Thailand) Company Limited, Bangkok 10900 (Thailand))

[P3-060-C]Field efficacy comparison of Enterisol^® Ileitis at a large Vietnamese farm

*HUY NGUYEN CONG¹, Truong Hoang Xuan¹, Thang Nguyen Nam ¹, Vu Tran Hoang¹, Rutger Jansen .² (1. Boehringer Ingelheim AH Vietnam (Viet Nam), 2. Boehringer Ingelheim Vetmedica GmbH (Germany))

[P3-063-C]Enterisol® Ileitis administration resulting in improved production performance and decreased fecal shedding of Lawsonia intracellularis

*Mamoru Tajima¹, Kazuhiko Yamada² (1. Front Circle inc. (Japan), 2. Boehringer Ingelheim Animal Health Japan Co., Ltd. (Japan))

[P3-066-C]PK/PD and clinical relationships of Pharmasin 250mg/g Premix (tylosin phosphate) and 100% Water Soluble Granules (tylosin tartrate) for the treatment of ileitis caused by Lawsonia intracellularis

*Ulrich KLEIN¹, Lieven Claerhout¹, Wouter Depondt¹ (1. Huvepharma NV (Belgium))

[P3-069-C]Effect of Enterisol® Ileitis Administration on Antibody Titer of Salmonella Typhimurium

Akiko Mitsuhashi¹, Kenshu Yamamoto¹, Koji Ishii², *Sae Nikaido³ (1. Shokukanken Inc. (Japan), 2. Summit Veterinary Services Ltd. (Japan), 3. Boehringer Ingelheim Animal Health Japan Co., Ltd. (Japan))

[P3-072-C]Characterization of Streptococcus suis and Public Awareness in a High-Risk Province of Thailand

*Perm Premphoolsawat¹, Khomsan Satchasataporn¹, Nattakan Meekhanon¹ (1. Department of Veterinary Nursing, Faculty of Veterinary Technology, Kasetsart University, Thailand (Thailand))

[P3-075-C]Duration of immunity against Erysipelothrix rhusiopathiae challenge in pig immunized with a novel inactivated porcine pleuropneumoniae and erysipelas combination vaccine.

*Kyoko Akashi¹, Kyoko Hirama², Leonardo Domingo Ellerma³ (1. Swine Business Unit, MSD Animal Health (Japan), 2. Product Development and Regulatory Affairs, MSD Animal Health (Japan), 3. MSD Animal Health (Phils) Inc (Philippines))

[P3-078-C]Effect of tylosin administration on intestinal microbiota development of pigs during the first six weeks post-weaning

*Ulrich KLEIN¹, Lieven Claerhout¹, Wouter Depondt¹, Sebastiaan Theus², Amanda Hettiarachchi² (1. Huvepharma NV (Belgium), 2. PathoSense BV (Belgium))

[P3-081-C]EFFICACY OF RHINISENG® IN A NURSERY SUFFERING POLYSEROSITIS PROBLEMS: IMPROVING SWINE RODUCTION PERFORMANCE ON KOREAN SWINE FARMS

*JeongJae Byun¹, Hyundong Noh¹, Sungwoon Choi¹, Sanghyun Noh¹, Joaquín M. Escuder², Jaehyuk Shin³ (1. HIPRA KOREA (Korea), 2. HIPRA HQ (Spain), 3. Dodram Pig farmers Coop. (Korea))

[P3-084-C]Evaluation of a one-shot recombinant vaccine against Erysipelas in pigs

Regis VIALLE³, *Mariko HAYASHI¹, Sarah KHARIEF², Juliette BEN AROUS², Nicolas VERSILLE² (1. SEPPIC (Japan), 2. SEPPIC FR (France), 3. SEPPIC SG (Singapore))

[P3-087-C]Real-Time PCR Detection of Enterotoxigenic Escherichia coli (ETEC) from Pig Feces in Farrowing-to-Finishing Pig Farms in Thailand

*Pornchalit Assavacheep¹, Suwannee Tongmalee¹, Sukuma Samngamnim¹, Chotika Pramarn², Apichaya Ratanamongkolmas², Wichaya Dee-ampai² (1. Department of Veterinary Medicine, Faculty of Veterinary Science, Chulalongkorn University (Thailand), 2. Elanco (Thailand), Co., Ltd. (Thailand))

[P3-090-C]Prevalence of Verotoxin-producing Escherichia coli(VTEC) on Chinese industrial swine farms

*wentao fei¹, Cong Li¹, Yanrui Ye¹, Tianning Yang¹, Hyun Dong Noh² (1. HIPRA CHINA (China), 2. HIPRA HQ (Spain))

[P3-093-C]Reduction of mortality in the nursery of a Taiwanese swine farm with clinical oedema disease by recombinant Verotoxin 2e (Vt2e) vaccine

*Chia-Fu Hsu¹, Amos Liao¹, Kelly Chen¹, Hyun Dong Noh², Ignacio Bernal Orozco² (1. HIPRA TAIWAN (Taiwan), 2. HIPRA HQ (Spain))

[P3-096-C]COMPARISON OF AUTOMATED SYSTEM VITEK-2 WITH CONVENTIONAL METHODS FOR ANTIBIOTIC SENSITIVITY IN STREPTOCOCCUS SUIS ISOLATED FROM SWINE

*Duangdaow Khunbutsri¹, Khomson Satchasataporn², Nusara Suwannachote³, Suphattra Jittimanee³, Nattakan Meekhanon² (1. Veterinary Diagnostic Laboratory, Faculty of Veterinary Medicine, KhonKaen University, KhonKaen 40002, Thailand. (Thailand), 2. Department of Veterinary Nursing, Faculty of Veterinary Technology, Kasetsart University, Bangkok 10900, Thailand. (Thailand), 3. Division of Pathobiology, Faculty of Veterinary Medicine, Khon Kaen University, Khon Kean, 40002, Thailand (Thailand))

[P3-099-C]Antimicrobial Susceptibility to Enrofloxacin of Actinobacillus pleuropneumoniae Isolated in Japan from 2003 to 2021

*Shunsuke AOKI¹, Takashi IWATA¹, Shinpei SASAMURA¹ (1. Elanco Japan K.K. (Japan))

[P3-102-C]SUPPLEMENTING PIGS WITH FLAVOPHOSPHOLIPOL REDUCES AMINOGLYCOSIDE RESISTANCE AND EXTENDED SPECTRUM BETA LACTAMASE (ESBL) ESCHERICHIA COLI

Kittitat Lugsomya², Padet Tummaruk², Nuvee Papasarakul², Wouter Van der Veken¹, *Ulrich Klein¹ (1. Huvepharma NV (Belgium), 2. Chulalongkorn University (Thailand))

[P3-105-C]COMPARISON OF INJECTABLE TOLTRAZURIL-GLEPTOFERRON AND ORAL TOLTRAZURIL+ IRON DEXTRAN FOR THE PREVENTION OF ANAEMIA AND COCCIDIOSIS UNDER THE FIELD CONDITIONS OF LARGE VIETNAM INTERGRATOR FARM

*Daniel Sperling¹, Xuan Doan², Bang Nguyen², Hai LE², Hamadi Karembe¹ (1. Ceva Sante Animale, France (France), 2. Ceva Sante Animale, Vietnam (Viet Nam))

[P3-108-C]Effects of injectable combined gleptoferron and toltrazuril on enhancing the quality of weaned piglets

*Naritsara Boonraungrod¹, Thongchai Amonrattanaporn¹, Kanitta Jitpreuk¹, Noppon Jiranart¹, Phawinwit Lawananon¹ (1. Ceva Animal Health (Thailand) Ltd. (Thailand))

[P3-111-C]Analysis of C.suis infection based on data from pig farms of two major group companies in China

Liwei Shi¹, Jun Zhang^1,2, Xueting Wen¹, Daniel Sperling³, *Yongxu Zhao¹ (1. Ceva Animal Health (China), 2. Nanjing Agricultural University (China), 3. Ceva Santé Animale (France))

[P3-114-C]Serotypes, virulence factors and multilocus sequence typing of Pasteurella multocida isolates from pigs with pneumonia in Korea (2016-2021)

Sung-Hyun Moon¹, Da-Yun Bae¹, Taek Geun Lee¹, Young-Seung Ko¹, Yun-Chae Cho¹, Ji-Min Hwang ¹, Dongseob Tark³, Won-Il Kim¹, Yeonsu Oh², *Ho-Seong Cho¹ (1. College of Veterinary Medicine and Bio-safety Research Institute, Jeonbuk National University (Korea), 2. College of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University (Korea), 3. Korea Zoonosis Research Institute, Jeonbuk National University (Korea))

Back to Category List